Alpha Biologics Sdn Bhd is at the forefront of the Government backed Malaysian Biotechnology industry. Our mammalian cell secreted protein contract manufacturing facility is the first stage of our growth and expansion in Malaysia. We will keep you aware of our progress through the pages of our website by publishing non-confidential and newsworthy items as they happen.

February  2008
Michelle Peake appointed Chief Operating Officer for Alpha Biologics Sdn Bhd

February 2007
Alpha Biologics set for growth following acquisition of CTM Biotech.

November 2006
Alpha Biologics secures further $3 million in latest funding round.

November 2005
Goodtrend Sdn.Bhd. appointed as local contractor for the construction of the Alpha Biologics Sdn.Bhd. facility.

October 2004
Alpha Biologics recruiting for a Director of Quality Assurance & Regulatory Affairs.

May 2004
The Alpha Biologics Sdn Bhd facility design undergoes successful FDA design review.

November 2003
Michelle Peake appointed Manufacturing Director for Alpha Biologics Sdn Bhd.

June 2003
Boccard Pharmaceutical and Food Division are appointed as the engineering contractors who will be responsible for the engineering design and construction of the Alpha Biologics Sdn Bhd Contract Manufacturing facility on the Penang BIOtech Park, Penang, Malaysia.